Fierce Healthcare July 24, 2020
Heather Landi

Two New York City metro health systems are collaborating with a startup to research the use of sensor-embedded clothing to monitor COVID-19 patients.

New Jersey-based Hackensack Meridian Health Systems and Maimonides Medical Center in Brooklyn, New York are working with Nanowear to use clinical-grade wearable technology—an undershirt with embedded nanosensors—to detect physiological and biomarker changes with patients either confirmed or suspected to have COVID-19.

Nanowear’s sensors can detect changes indicative of clinical deterioration that may require further intervention from the hospital systems, according to the company. In 2016, the New York City-based startup received clearance from the Food and Drug Administration (FDA) for its SimplECG, a remote cardiac monitoring undergarment.

The research collaboration with Hackensack and Maimonides involves Nanowear’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Technology, Wearables
Your Earphones And Headphones As Health And Medical Devices
Wearable Devices for Parkinson’s Disease: The Future Is Here
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Amwell’s Roy Schoenberg talks about telehealth and broader views of virtual care
AI Translates Nature into New Medicines | StartUp Health Insights: Week of Nov 26, 2024

Share This Article